AP
RETA

Atlas Principals’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Atlas Principals’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$1.56M – 35
2020
Q2 		$1.56M Buy
10,000
+5,000
+100% +$780K 1.16% 19
2020
Q1 		$722K Buy
+5,000
New +$722K 0.69% 23